Qualified Health obtains $125M to revolutionize healthcare with generative AI

In 2026, the convergence of healthcare and artificial intelligence reaches a major milestone with the announcement of a colossal funding round: Qualified Health secures 125 million dollars to deploy generative AI within the American hospital systems. This start-up, created in 2023, is gradually establishing itself as a key player in the digital transformation of medicine thanks to an innovative approach focused on securing, governing, and operationally integrating advanced technologies. This financing, led by the renowned venture capital fund New Enterprise Associates and enriched by strategic investors such as Anthropic or Cathay Innovation, attests to the growing trust in technological innovation serving healthcare. With a valuation between 500 million and 1 billion dollars, Qualified Health perfectly illustrates the disruptive potential of generative AI to improve the quality, safety, and efficiency of hospital establishments.

Beyond a simple digital platform, this start-up offers a comprehensive infrastructure enabling the transformation of health data into tangible solutions, while meeting increasingly strict regulatory requirements in the medical sector. This revolution accompanies an ambitious vision: to support hospitals in implementing reliable, traceable, and audited artificial intelligence tools with a real clinical and financial impact. These ambitions reflect the fundamental challenges faced by hospital administrators who no longer settle for isolated pilot projects but now demand widespread, secure, and measurable adoption.

A strategic fundraising to transform health systems through generative AI

The exceptional 125 million dollar fundraising by Qualified Health reflects a sharp awareness of the revolutionary potential of artificial intelligence in healthcare. Founded recently, in 2023, the company quickly attracted major investors, leveraging sharp expertise at the intersection of technological innovation and the hospital sector. In this respect, New Enterprise Associates (NEA), an internationally renowned venture capital fund, led this Series B round, relying on partners like Transformation Capital, GreatPoint Ventures, as well as the Anthology fund from Menlo Ventures. This diversified pool demonstrates strategic alignment around the future of medical technologies serving patient care.

This massive capital injection takes place in a context where health establishments face growing challenges: managing complex data, the need to improve clinical outcomes while reducing costs, strong regulatory pressure, and the need to optimize operational flows. In this framework, artificial intelligence, and more specifically generative AI, becomes an essential lever. However, for this revolution to be sustainable, hospitals demand partners capable of deploying these technologies securely, scalably, and compliantly.

These investors, many of whom had already trusted Qualified Health during previous rounds — 5 million dollars during the very first funding, then 25 to 30 million during the Series A at the end of 2024 — thus confirm their willingness to support the start-up in its growth. With a total of 155 million dollars raised to date, the company positions itself as a technological leader at the crossroads of healthcare and digitalized innovation.

Such a level of financing will allow Qualified Health to accelerate the development of its medical AI management platform, strengthen its engineering team, and expand its commercial presence across the United States. The goal? To meet the increasing expectations of hospital systems, which now evaluate every investment based on its clinical impact, return on investment, and regulatory compliance.

Qualified Health’s comprehensive platform: a pillar for the secure integration of artificial intelligence in hospitals

Qualified Health has made the bet to develop a complete AI infrastructure, designed from the start to meet the specificities of the hospital environment. Unlike fragmented solutions often reserved for pilot projects, the platform offers a global response, ranging from data integration to team training, including continuous workflow supervision and evaluation of AI agents.

This “holistic” approach is essential in a sector as sensitive as healthcare. Each deployed algorithm must be continuously validated, its decisions traceable and explainable, its performance audited, all while ensuring patient safety and data confidentiality. With this in mind, Qualified Health integrates numerous features:

• Clinical supervision: ensuring expert monitoring of AI interventions to prevent medical errors.
• Auditability: enabling regular and independent reviews of artificial intelligence decisions.
• Complete traceability: recording every step, every data point, every impact produced by the technology on the patient.
• Source attribution: knowing precisely which data and algorithms were used for each recommendation.
• Post-deployment monitoring: quickly detecting any drift or anomaly over time.

These features guarantee not only regulatory compliance, particularly with criteria imposed by the FDA in the United States, but also the trust of care teams, who can thus rely on a safe and transparent system. Justin Norden, co-founder and CEO of the company, emphasizes this crucial dimension: “It’s not just about implementing AI, but building a true ecosystem where every stakeholder can contribute to improving care efficiency while protecting patients.”

Moreover, the platform offers a flexible integration framework that adapts to different hospital systems. It therefore facilitates the integration of AI into existing workflows, often complex and heterogeneous, without disrupting processes. This adaptability is a fundamental differentiating factor explaining its growing adoption by prestigious hospital groups.

Table of key features of the Qualified Health platform

Feature	Description	Impact on Healthcare
Data integration	Centralization and standardization of patient records and other clinical data	Improves the quality of diagnoses and medical decisions
Clinical supervision	Real-time monitoring of algorithms to ensure safety	Reduces AI-related error risks
Auditability	Independent reviews to validate performance and compliance	Regulatory compliance and increased transparency
Complete traceability	Precise logging of decisions and data flows	Digital conference of medical records
Team training	Tailored programs for medical and administrative staff	Better adoption and use of AI tools

Key collaborations establishing the credibility of Qualified Health in the American hospital market

It is no coincidence that major institutions such as Emory Healthcare, University of Rochester Medicine, or the University of Texas system and its eight establishments – including the MD Anderson Cancer Center – have chosen to rely on Qualified Health. These partnerships mark a major turning point where AI is no longer a mere experiment but a truly operational tool creating value.

The results speak for themselves. At the University of Texas Medical Branch (UTMB), data centralization via the platform enabled the deployment of automated assistants, generating a tangible effect on hospital operations and economic gains estimated at over 15 million dollars in a few years. This success perfectly illustrates the potential of AI to optimize workflow management, improve patient care, and reduce structural costs.

At Emory Healthcare, artificial intelligence tools are carefully integrated to support the transformation of the patient experience. This approach is not only about automation but genuine support, securing intervention while strengthening the quality of care. Similarly, at University of Rochester, generative AI is employed to smooth administrative flows without ever compromising clinical standards, a balance that is both delicate and necessary.

According to estimates published by specialized press, Qualified Health now counts more than 400,000 active users in the American hospital network, representing about 5% of these hospitals’ revenue. This early adoption underscores the trust granted to the technology as well as the concrete relevance of the solutions offered.

Experience and expertise at the heart of Qualified Health’s leadership

Qualified Health’s success relies as much on its technological approach as on the richness and diversity of its management team. Its founders combine rare expertise blending healthcare, artificial intelligence, public policy, and hospital management. Justin Norden, CEO, former Stanford professor, and ex-leader of TrustworthyAI, embodies this alliance of academic knowledge and entrepreneurial leadership.

Alongside him, Kedar Mate, former director of the Institute for Healthcare Improvement, brings valuable experience in continuous care improvement, while Shantanu Phatakwala, with a background in companies such as Haven or Evolent Health, is well versed in the strategic challenges of hospital management. Beau Norgeot, former VP of AI at Elevance, completes this quartet with deep technical and operational expertise.

This combination of expertise enabled early anticipation of an unavoidable need: a platform capable of evaluating, deploying, and governing AI agents in a regulated context, which is slowly but surely becoming an industry standard. This enlightened vision is one of the major reasons why Qualified Health attracts so much interest and funding.

The major strengths of Qualified Health’s leadership

• A thorough understanding of regulatory and ethical issues in healthcare.
• A proven ability to develop reliable and compliant technologies.
• An extensive network of partners in the hospital and research sectors.
• A strategic vision focused on long-term AI adoption and industrial integration.
• A strong commitment to data security and transparency in healthcare.

Major challenges to overcome for widespread adoption of generative AI in healthcare

Implementing generative AI solutions in hospitals remains a complex undertaking. In 2026, several major obstacles still persist despite technological advances. The first challenge concerns the very nature of medical applications: in many cases, an AI is considered a medical device, which subjects it to very strict approval rules, especially in the United States via the FDA.

Qualified Health must therefore demonstrate absolute reliability and ensure that its products pose no risk to patients. This requirement is notably translated into the necessity to integrate sophisticated traceability systems allowing every AI decision to be retraced. Without this transparency, acceptability by authorities and health professionals would be compromised.

Moreover, the ongoing skepticism among caregivers towards these technologies necessitates an in-depth phase of support and training. Medical personnel must be reassured that these tools will improve their daily work without complicating crucial aspects. This requires patient work on modifying workflows and gradually instilling an AI culture within departments.

Finally, on an economic scale, the transition from pilot projects to large-scale deployments with a genuinely measurable impact in terms of financial gains and care quality remains a challenge. Despite encouraging signs, Qualified Health must ensure that its solutions can be generalized without generating negative effects or unforeseen excessive costs.

The future of medical technology through the example of Qualified Health

Qualified Health’s journey perfectly illustrates the profound evolution healthcare is experiencing in 2026 thanks to artificial intelligence. Where a few years ago, medical technology was often limited to management tools or experimental applications, generative AI is now established as a true driver of organizational and clinical transformation. The ability to make these applications robust, reliable, and accompanied by rigorous governance becomes a determining criterion to access a highly demanding market.

In this perspective, massive investments made allow envisioning a future where every hospital can fully leverage its historical and real-time data, relying on intelligent tools capable of best supporting healthcare personnel. This heralds a new era where quality of care and economic control will be based on a synergy between innovation, safety, and respect for ethical rules.

We can also anticipate that ongoing reflections on regulation and AI accountability in the medical field will continue to evolve, making platforms like the one developed by Qualified Health indispensable. Indeed, securing and continuously evaluating generative artificial intelligence systems becomes a prerequisite for their large-scale adoption in hospitals, not only in the United States but also internationally.